Literature DB >> 4063167

Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease.

F Kaneko, Y Takahashi, R Muramatsu, K Adachi, Y Miura, A Nakane, T Minagawa.   

Abstract

We have studied NK cell activity and numbers in the peripheral blood obtained from patients with Behcet's disease and from normal healthy controls. NK cell activity in the peripheral blood of patients in the clinically-active stage of Behcet's disease was significantly lower than that of patients in the inactive stage and normal controls. In contrast, it was observed that the actual number of NK cells was markedly increased in the peripheral blood of patients with active disease. The addition of alpha-interferon (INF-alpha) to these cells showed significant augmentation of NK cell activity. These results suggest that the patients with active Behcet's disease lack a factor which activates NK cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063167     DOI: 10.1111/j.1365-2133.1985.tb02083.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

3.  Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  A M Jennings; G Wild; J D Ward; A M Ward
Journal:  Br J Ind Med       Date:  1988-10

4.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

5.  Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Authors:  Ishna Auluck; Ayesha Karimi; Simon Taylor
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

6.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

7.  Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease.

Authors:  Mitsuhiro Takeno; Yoshihiro Shimoyama; Jun-Ichi Kashiwakura; Hiroko Nagafuchi; Tsuyoshi Sakane; Noboru Suzuki
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

8.  Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.

Authors:  Bharati Sanjanwala; Monia Draghi; Paul J Norman; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex.

Authors:  Meeyoung Lee; Bunsoon Choi; Hyuk Jae Kwon; Ju A Shim; Kyung Sook Park; Eun-So Lee; Seonghyang Sohn
Journal:  J Inflamm (Lond)       Date:  2010-06-24       Impact factor: 4.981

10.  Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions.

Authors:  Ozgür Gündüz
Journal:  Patholog Res Int       Date:  2011-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.